However, recently Buettner et al. [43] revealed that teriflunomide inhibits PIM family of serine/threonine kinases (PIMs) in MM cells, and in this way downregulates c-Myc expression and inhibits cell proliferation. Here, MARK2 is linked to Miyoshi myopathy.